At baseline, at 0 months of treatment of either AGE or placebo, the IL-6 concentration was 4.762 ± 0.701 ng/L in the AGE group and 4.173 ± 0.653 ng/L in the placebo group (p > 0.05). The gene discussed is IL6; the disease is age.